Magnitude of and outcome associated with inappropriate prescribing in heart failure with reduced ejection fraction: an analysis of 50 348 patients from the Swedish Heart Failure Registry
Nearly half of HFrEF patients received PIP medications, particularly those with multimorbidity, which was independently associated with worse outcomes and less GDMT use. Our data underscore the need for targeted strategies to reduce inappropriate prescribing in HFrEF.
Authors
- G. Rosano
- Gianluigi Savarese (ORCID: https://orcid.org/0000-0001-7732-0887)
- Lina Benson
- Peter G M Mol
- Amr M. Abdin
- Carin Corovic Cabrera
- Alicia Uijl (ORCID: https://orcid.org/0000-0003-2835-7741)
- Felix Lindberg (ORCID: https://orcid.org/0000-0002-7380-9877)
- R Scorza (ORCID: https://orcid.org/0000-0002-4781-9588)
- Seif El-Hadidi
Institutions
- University Medical Center Groningen (NL)
- Karolinska University Hospital (SE)
- Royal College of Surgeons in Ireland (IE)
- Vita-Salute San Raffaele University (IT)
- Karolinska Institutet (SE)
- San Raffaele University of Rome (IT)
- Universitätsklinikum des Saarlandes (DE)
- Stockholm South General Hospital (SE)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- IRCCS Ospedale San Raffaele (IT)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Saarland University (DE)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1093/ejhf/xuaf026
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 27.18